Artemisinin relieves myocardial ischemia-reperfusion injury via modulating miR-29b-3p and hemicentin 1 (vol 13, 918966, 2022)

被引:0
|
作者
Han, Junyu [1 ]
Zhang, Ziguan [1 ]
Zhang, Zhonghe [1 ]
Yang, Shuyu [2 ]
机构
[1] Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Cardiol, Xiamen, Fujian, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Xiamen Diabet Inst, Sch Med, Xiamen, Fujian, Peoples R China
关键词
myocardial ischemia-reperfusion; artemisinin; high throughput sequencing; miR-29b-3p; hemicentin; 1; oxidative stress;
D O I
10.3389/fphar.2023.1169734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [31] OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression
    Liu, Naixin
    Fan, Yan
    Li, Yilin
    Zhang, Yingxuan
    Li, Jiayi
    Wang, Yinglei
    Wang, Zhuo
    Liu, Yixiang
    Li, Yuansheng
    Kang, Zijian
    Peng, Ying
    Ru, Zeqiong
    Yang, Meifeng
    Feng, Chengan
    Wang, Ying
    Yang, Xinwang
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (12) : 2550 - 2562
  • [32] CircBAZ1B stimulates myocardial ischemia/reperfusion injury (MI/RI) by modulating miR-1252-5p/ATF3mediated ferroptosis
    Wei, Ruili
    Yang, Tianxiao
    Li, Weihong
    Wang, Xiqian
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (06)
  • [33] Lncrna FGD5-AS1 Aggravates Myocardial Ischemia-Reperfusion Injury by Sponging Mir-129-5p
    Wei, Peng
    Dong, Zhifeng
    Lou, Ming
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2022, 51 (10) : 2281 - 2288
  • [34] Long noncoding RNA NEAT1 sponges miR-495-3p to enhance myocardial ischemia-reperfusion injury via MAPK6 activation
    Luo, Man
    Sun, Qingsong
    Zhao, Hongmei
    Tao, Jiali
    Yan, Dongsheng
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (01) : 105 - 113
  • [35] RETRACTION: Reduction of miR-29a-3p induced cardiac ischemia reperfusion injury in mice via targeting Bax
    Zhang, Liang
    Zhang, Jian
    Tong, Qiguang
    Wang, Guannan
    Dong, Hongling
    Wang, Zhonglu
    Sun, Qi
    Wu, Hangyu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2025, 29 (02)
  • [36] Fluvastatin attenuates myocardial ischemia-reperfusion injury through increased eNOS bioavailability via the P13-kinase/Akt pathway
    Matsuki, Akira
    Igawa, Akihiko
    Nozawa, Takashi
    Suzuki, Takayuki
    Fujii, Nozomu
    Ueno, Hitoshi
    Inoue, Hiroshi
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (08) : S166 - S166
  • [37] MiR-219a-2 relieves myocardial ischemia-reperfusion injury by reducing calcium overload and cell apoptosis through HIF1α/ NMDAR pathway
    Hu, Fudong
    Zhang, Shengye
    Chen, Xi
    Fu, Xin
    Guo, Shengcun
    Jiang, Zhengming
    Chen, Kui
    EXPERIMENTAL CELL RESEARCH, 2020, 395 (01)
  • [38] Dexmedetomidine alleviates myocardial ischemia-reperfusion injury by down-regulating miR-34b-3p to activate the Jagged1/Notch signaling pathway
    Guo, Peng
    Yi, Han
    Han, Mingming
    Liu, Xinxin
    Chen, Kemin
    Qing, Jie
    Yang, Fengrui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 116
  • [39] lncRNA HAGLR modulates myocardial ischemia-reperfusion injury in mice through regulating miR-133a-3p/MAPK1 axis
    Wang, Zi
    Luo, Wenqi
    Zhong, Peng
    Feng, Yifan
    Wang, Huaibin
    OPEN MEDICINE, 2022, 17 (01): : 1299 - 1307
  • [40] Dexmedetomidine regulates exosomal miR-29b-3p from macrophages and alleviates septic myocardial injury by promoting autophagy in cardiomyocytes via targeting glycogen synthase kinase 3β
    Yu, Tianyi
    Liu, Hsinying
    Gao, Min
    Liu, Dan
    Wang, Jiaqiang
    Zhang, Jie
    Wang, Jizhuang
    Yang, Peilang
    Zhang, Xiong
    Liu, Yan
    BURNS & TRAUMA, 2024, 12